530057 — Vivanza Biosciences Share Price
0.000.00%
Last trade - 00:00- IN₹91.60m
- IN₹152.28m
- IN₹278.35m
- 17
- 45
- 14
- 11
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.86 | ||
| Price to Tang. Book | 2.79 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.81 | ||
| EV to EBITDA | 33.31 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5.63% | ||
| Return on Equity | -1.83% | ||
| Operating Margin | 3.84% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 96.21 | 98.88 | 104 | 178.07 | 278.35 | n/a | n/a | 59.94% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +342.11 | +79.68 | -6.4 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Vivanza Biosciences Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of pharmaceutical products. Its products include gloves and surgical. Its Gloves products include latex examination gloves powdered, latex surgical powder free, latex free examination gloves-vinyl, latex free examination gloves-nitrile, and latex surgical powdered. The Company’s products catalogues include Injectable Products, Vivanza Gloves, Therapeutic Index Injection, Veterinary Product, and Veterinary Feed. The Company offers gloves and surgical products to the industries include chemical, energy, industry, manufacturing and materials.
Directors
- Jainil Bhatt CFO
- Aesha Mashru CCO
- Bhatt B. MDR (73)
- Hemant Parikh NED (57)
- Manali Patel NID
- Sunil Shah NID (40)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 6th, 1982
- Public Since
- February 21st, 1995
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 40,000,000
- Address
- 403 Sarthik II, S G Road, AHMEDABAD, 380054
- Web
- https://www.vivanzabiosciences.com/
- Phone
- +91 7926870952
- Auditors
- M/S. SHIVAM SONI & CO.
Upcoming Events for 530057
Q1 2026 Vivanza Biosciences Ltd Earnings Release
Q2 2026 Vivanza Biosciences Ltd Earnings Release
Similar to 530057
Aayush Wellness
Bombay Stock Exchange
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
FAQ
What is the Vivanza Biosciences share price?
As of Today at 24:01 UTC, shares in Vivanza Biosciences are trading at IN₹2.29. This share price information is delayed by 15 minutes.
How has the Vivanza Biosciences share price performed this year?
Shares in Vivanza Biosciences last closed at IN₹2.29 and the price had moved by -71.48% over the past 365 days. In terms of relative price strength the Vivanza Biosciences share price has underperformed the S&P BSE 100 Index by -73.14% over the past year.
What are the analyst and broker recommendations for Vivanza Biosciences?
There is no consensus recommendation for this security.
Find out moreWhat is the Vivanza Biosciences dividend yield?
Vivanza Biosciences does not currently pay a dividend.
Does Vivanza Biosciences pay a dividend?
Vivanza Biosciences does not currently pay a dividend.
When does Vivanza Biosciences next pay dividends?
Vivanza Biosciences does not currently pay a dividend.
How do I buy Vivanza Biosciences shares?
To buy shares in Vivanza Biosciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Vivanza Biosciences?
As of the previous close price of IN₹2.29, shares in Vivanza Biosciences had a market capitalisation of IN₹91.60m.
Where are Vivanza Biosciences shares listed?
Here are the trading details for Vivanza Biosciences:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 530057
What kind of share is Vivanza Biosciences?
Based on an overall assessment of its quality, value and momentum Vivanza Biosciences is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Vivanza Biosciences share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Vivanza Biosciences share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vivanza Biosciences. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -35.4%.
As of the last closing price of IN₹2.29, shares in Vivanza Biosciences were trading -34.86% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Vivanza Biosciences PE Ratio?
The Vivanza Biosciences PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹2.29.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Vivanza Biosciences?
Vivanza Biosciences' management team is headed by:
- Jainil Bhatt - CFO
- Aesha Mashru - CCO
- Bhatt B. - MDR
- Hemant Parikh - NED
- Manali Patel - NID
- Sunil Shah - NID